Safety profile of risankizumab in the treatment of psoriasis patients with concomitant hepatitis B or C infection: A multicentric retrospective cohort study of 49 patients

J Eur Acad Dermatol Venereol. 2023 Oct;37(10):e1203-e1207. doi: 10.1111/jdv.19186. Epub 2023 May 18.

Christian Ciolfi¹, Riccardo Balestri², Federico Bardazzi³, Martina Burlando^{4

5}, Karin Chersi⁶, Antonio Costanzo^{7

8}, Paolo Dapavo⁹, Paolo Gisondi¹⁰, Piergiorgio Malagoli¹¹, Miriam Pizzolato¹², Giulia Rech², Francesco Paolo Russo^{13

14}, Sara Battistella^{13

14}, Stefano Piaserico¹

¹ Dermatology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.
² Division of Dermatology, Santa Chiara Hospital, Trento, Italy.
³ Unit of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, IRCCS Sant'Orsola Polyclinic, University of Bologna, Bologna, Italy.
⁴ Department of Dermatology, Dipartimento di Scienze della Salute-DISSAL, University of Genoa, Genoa, Italy.
⁵ IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
⁶ ASUGI-Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy.
⁷ Unit of Dermatology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
⁸ Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
⁹ Department of Medical Sciences, Section of Dermatology, University of Turin, Torino, Italy.
¹⁰ Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.
¹¹ Dermatology Unit, Azienda Ospedaliera San Donato Milanese, Milan, Italy.
¹² Division of Dermatology, Santa Maria della Misericordia Hospital, Rovigo, Italy.
¹³ Gastroenterology and Multivisceral Transplant Unit, Azienda Ospedale - Università di Padova, Padua, Italy.
¹⁴ Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.

No abstract available

Publication types